Table 1.

Clinical Trials of Epigenetic Therapies in AML from ClinicalTrials.gov, accessed May 2014

Clinical Trials of Epigenetic Therapies in AML from ClinicalTrials.gov, accessed May 2014
Clinical Trials of Epigenetic Therapies in AML from ClinicalTrials.gov, accessed May 2014

*DNMTi=DNA Methyltransferase Inhibitors.

**HDAC=Histone Deacetylase.

***HMT=Histone Methyltransferase.

****BET=Bromo and Extra Terminal.

ß: A=azacitidine, B=bortezomib, BR=brentuximab, C=cytarabine, CL=clofarabine, D=decitabine, DA=daunorubicin, E=etoposide, EN=entinostat, ER=erismodegib, GO=gemtuzumab ozogamicin, HI=hedgehog inhibitor, I=idarubicin, L=lenalidomide, M=mitoxantrone, MD=midostaurin, P=panobinostat, PR=pracinostat, R=rigosertib, RA=rapamycin, RBV=ribavirin, S= selinexor, SI=sirolimus, SO=sorafenib, T=temozolomide V=vosaroxin, VA= valproic acid, VO=volasertib, VOR=vorinostat.

Close Modal

or Create an Account

Close Modal
Close Modal